We are live on
!
Find out more
PI
Putnam Investments Portfolio holdings
AUM
$75.7B
1-Year Est. Return
34.45%
This Fund
S&P 500
This Quarter
Est. Return
-2.34%
1 Year Est. Return
+34.45%
3 Year Est. Return
+61.95%
5 Year Est. Return
+203.43%
10 Year Est. Return
+442.91%
AUM
$52.6B
AUM Growth
-$3.21B
(-5.8%)
Cap. Flow
-$1.26B
Cap. Flow
% of AUM
-2.4%
Top 10 Holdings %
Top 10 Hldgs %
24.55%
Holding
1,245
New
126
Increased
333
Reduced
642
Closed
106
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ingersoll Rand
IR
|
+$286M |
| 2 |
Humana
HUM
|
+$224M |
| 3 |
Eli Lilly
LLY
|
+$143M |
| 4 |
Abbott
ABT
|
+$110M |
| 5 |
Ball Corp
BALL
|
+$104M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$518M |
| 2 |
Eaton
ETN
|
+$267M |
| 3 |
Northrop Grumman
NOC
|
+$221M |
| 4 |
Fidelity National Information Services
FIS
|
+$211M |
| 5 |
Aramark
ARMK
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.38% |
| 2 | Healthcare | 18.47% |
| 3 | Financials | 12.77% |
| 4 | Consumer Discretionary | 10.16% |
| 5 | Industrials | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Gilead Sciences
GILD
$165B
| $531K | ﹤0.01% |
8,609
-157
| -2% | -$9.9K |
|
827
FS KKR Capital
FSK
$3.37B
| $530K | ﹤0.01% |
+31,249
| New | +$652K |
|
828
Ares Capital
ARCC
$14.3B
| $528K | ﹤0.01% |
+31,315
| New | +$605K |
|
829
CTS Corp
CTS
$1.85B
| $528K | ﹤0.01% |
12,683
-227
| -2% | -$9.11K |
|
|
RAPT
830
DELISTED
RAPT Therapeutics
RAPT
| $525K | ﹤0.01% |
2,728
+237
| +10% | +$44.8K |
|
831
New Jersey Resources
NJR
$5.45B
| $523K | ﹤0.01% |
13,533
-248
| -2% | -$11.1K |
|
|
AEL
832
DELISTED
American Equity Investment Life Holding Company
AEL
| $521K | ﹤0.01% |
13,974
-255
| -2% | -$9.57K |
|
833
BioCryst Pharmaceuticals
BCRX
$2.51B
| $518K | ﹤0.01% |
41,155
-748
| -2% | -$9.63K |
|
834
IBM
IBM
$223B
| $516K | ﹤0.01% |
4,340
+668
| +18% | +$87.7K |
|
835
Standex International
SXI
$3.98B
| $516K | ﹤0.01% |
6,319
-113
| -2% | -$10.1K |
|
836
Eagle Bancorp
EGBN
$843M
| $507K | ﹤0.01% |
11,324
-202
| -2% | -$9.65K |
|
837
Titan International
TWI
$457M
| $503K | ﹤0.01% |
41,421
-745
| -2% | -$10.7K |
|
838
Crocs
CROX
$6.63B
| $495K | ﹤0.01% |
7,210
+324
| +5% | +$22.5K |
|
839
ESCO Technologies
ESE
$7.79B
| $484K | ﹤0.01% |
6,592
-116
| -2% | -$9K |
|
|
SEM
840
DELISTED
Select Medical
SEM
| $484K | ﹤0.01% |
40,617
-87,352
| -68% | -$1.24M |
|
|
NGM
841
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $483K | ﹤0.01% |
36,900
-666
| -2% | -$10.1K |
|
842
NETSCOUT
NTCT
$2.81B
| $474K | ﹤0.01% |
15,142
-273
| -2% | -$8.93K |
|
843
Selective Insurance
SIGI
$5.66B
| $472K | ﹤0.01% |
5,801
-103
| -2% | -$8.39K |
|
844
SunCoke Energy
SXC
$799M
| $471K | ﹤0.01% |
81,153
-1,474
| -2% | -$9.9K |
|
|
TCDA
845
DELISTED
Tricida, Inc. Common Stock
TCDA
| $467K | ﹤0.01% |
+44,551
| New | +$487K |
|
846
National Health Investors
NHI
$3.59B
| $466K | ﹤0.01% |
8,237
-148
| -2% | -$9.33K |
|
|
NVEE
847
DELISTED
NV5 Global
NVEE
| $465K | ﹤0.01% |
15,016
+2,124
| +16% | +$69.4K |
|
|
DOOR
848
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $465K | ﹤0.01% |
6,513
-116
| -2% | -$9.64K |
|
|
IGMS
849
DELISTED
IGM Biosciences
IGMS
| $460K | ﹤0.01% |
20,235
-356
| -2% | -$7.19K |
|
850
Crinetics Pharmaceuticals
CRNX
$8.93B
| $458K | ﹤0.01% |
23,351
-423
| -2% | -$8.63K |
|
Similar funds
MGIM
BC
WMSA
SS
PMEF
CC
GW
GC
Putnam Investments's Q3 2022 Portfolio in Review
As of Q3 2022, Putnam Investments held 1,245 positions worth $52.6B, down 5.8% from $55.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Putnam Investments's Q3 2022 filing shows 126 new, 333 increased, 642 reduced and 106 closed positions. Its largest new stake was iShares MSCI India ETF: 303,491 shares worth $12.4M. The largest sale was Johnson & Johnson, an estimated $518M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Putnam Investments's largest Q3 2022 buy was iShares MSCI India ETF: 303,491 shares worth $12.4M.
- Putnam Investments added most to Ingersoll Rand in Q3 2022, an estimated $286M increase.
- Putnam Investments's biggest Q3 2022 reduction was Johnson & Johnson, cutting an estimated $518M.
- Putnam Investments fully exited Pershing Square Tontine Holdings, Ltd. in Q3 2022, selling an estimated $34.2M.
- Putnam Investments's ten largest holdings make up 25% of its $52.6B portfolio in Q3 2022.
- Putnam Investments opened 126 new positions and closed 106 in Q3 2022.
- Putnam Investments's portfolio value fell 5.8% quarter-over-quarter to $52.6B.
Based on Putnam Investments's 13F filing for Q3 2022, filed 14 Nov 2022.